Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral Sciences
Agency
National Institutes of Health
Posted
Sep 22, 2026
Due Date
May 25, 2027
Description
<p>The National Institute of Neurological Disorders and Stroke (NINDS), in collaboration with other National Institutes of Health (NIH) Institutes, Centers, and Offices, intends to support research projects that directly improve or evaluate biomedical and behavioral rigor, replicability, and reproducibility. Example projects include, but are not limited to:</p><ul><li data-list-item-id="ebe514fb56922402833157d15d0d48621">Assessing the scientific and behavioral impact of improving rigor, replicability, and reproducibility</li><li data-list-item-id="eeee38cd0bd6cb4566588aa20331352a4">Developing decision-making frameworks to select candidate studies for replication with the highest potential for scientific value or novel insights</li><li data-list-item-id="ee853e4ecc877f86b7b330ccbe301719e">Measuring replicability, reproducibility, robustness, and generalizability of important research findings to accelerate scientific innovation</li></ul><p>Applications are not being solicited at this time. This notice is to allow applicants time to develop collaborations and responsive projects. </p>
AI Summary
Agency: National Institutes of Health
Details
- Notice ID
- 363915
- Solicitation Number
- PAR-28-061
- Classification Code
- D
Want to track opportunities like this?
Sign up for Kontratar to get AI-powered opportunity matching, ranking, and alerts.
Get Started FreeRelated opportunities
- Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)
National Institutes of Health
- Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)
National Institutes of Health
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)
National Institutes of Health
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
National Institutes of Health